Business Context and Reporting Period
This Form 8-K is filed by TransBiotec, Inc. (not SOBR Safe, Inc., which is the name of the company's product) with a report date of July 10, 2014, and a signature date of September 12, 2014. The filing discloses the entry into a material definitive agreement regarding the distribution of the company's SOBR alcohol testing device.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate agreement rather than financial performance data.
Material Changes
On July 10, 2014, TransBiotec, Inc. entered into a Master Distribution Agreement with A.G. Global Capital ("A.G. Global"). Under this agreement, A.G. Global was appointed as the exclusive distributor of the SOBR alcohol testing device in the following regions:
- Republic of Turkey
- Kingdom of Sweden
- Gulf Cooperation Council (GCC) countries: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates
- Republic of Azerbaijan
Guidance, Outlook, and Risks
The filing includes a press release issued on September 10, 2014, announcing the agreement. The document contains no specific financial guidance, forward-looking projections, or detailed risk factors beyond the standard Regulation FD disclosure stating that the information is not deemed "filed" for liability purposes under Section 18 of the Exchange Act unless expressly incorporated by reference.
Investor Verification Checklist
- Verify the operational status and financial health of the new exclusive distributor, A.G. Global Capital.
- Confirm the specific terms of the Master Distribution Agreement, including royalty rates or minimum purchase obligations, which are not detailed in this summary.
- Assess the market potential for alcohol testing devices in the newly covered regions (Turkey, Sweden, GCC, Azerbaijan).
- Review the attached press release (Exhibit 99.1) for additional details on the strategic rationale.